Infinity Pharmaceuticals (INFI) announced that, based on a preliminary vote count, its stockholders have adopted the previously announced merger agreement providing for the merger with MEI Pharma (MEIP) at the special meeting of Infinity stockholders held earlier today. The transaction remains subject to approval by MEI stockholders.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on INFI:
- MEI Pharma reminds shareholders to vote for Infinity merger
- Infinity Pharmaceuticals provides additional information on MARIO-8 study design
- ISS recommends Infinity Pharma stockholders vote for MEI Pharma merger
- MEI Pharma: Letter to holders highlights value of Infinity Pharma transaction
- Anson, Cable Car vote against proposed MEI Pharma, Infinity transaction